Niraparib+Abiraterone Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 100mg+500mg / 200mg+1000mg
Reference Brands: AKEEGA (USA/EU)
Category: Oncology Cancer Care
Niraparib/Abiraterone is an oral dual-action anticancer therapy used for BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). Niraparib is a PARP inhibitor that blocks DNA repair in cancer cells, leading to cell death, while Abiraterone acetate inhibits androgen biosynthesis, reducing tumor growth driven by male hormones. The combination is taken once daily with prednisone and is designed to improve treatment efficacy by targeting cancer through two complementary mechanisms. It is available as film-coated tablets in varying strengths. Niraparib+Abiraterone is available in Tablet and strengths such as 100mg+500mg / 200mg+1000mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Niraparib+Abiraterone is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Niraparib+Abiraterone can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
